Form 4: Chemours CFO Equity Vesting Tax Withholding

Chemours Company's CFO, Shane Hostetter, had 3,021 shares withheld to cover tax obligations related to vesting equity awards.

Summary

• Shane Hostetter, Chief Financial Officer of The Chemours Company, had 3,021 shares of common stock withheld.
• The shares were withheld on August 6, 2025, at a price of $12 per share.
• This transaction was to satisfy tax obligations arising from the vesting of restricted stock units and dividend equivalent units.
• No shares were sold in the open market; this was an automatic withholding for tax purposes.
• Following this transaction, Mr. Hostetter beneficially owns 57,115.1539 shares of Chemours Common Stock.
• The transaction is exempt from Section 16(b) pursuant to Rule 16b-3.

Sentiment

Score: 5

Explanation: Neutral. This is a routine, non-discretionary transaction related to executive compensation and tax obligations, indicating the vesting of equity awards rather than a sale.

Positives

• Indicates the vesting of restricted stock units and dividend equivalent units, suggesting continued equity compensation for the CFO.
• The transaction was an automatic withholding for tax obligations, not a discretionary sale by the CFO.

Negatives

• A reduction in the number of shares directly held by the CFO, albeit for tax purposes.

Future Outlook

NA

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically a tax-related withholding of shares for equity compensation. It does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary tax withholding, not a sale. It confirms the vesting of executive equity awards.
• Employees: No direct impact on general employees.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary transaction where shares were withheld to cover tax obligations related to the vesting of executive equity awards. It does not reflect a change in the company's fundamentals, strategic direction, or the CFO's discretionary investment decision. Therefore, it provides no new information that would warrant a change in investment recommendation based solely on this filing.

Keywords

Chemours Company, CC, Shane Hostetter, CFO, Form 4, SEC filing, insider transaction, equity compensation, restricted stock units, tax withholding